WILMINGTON, MASSACHUSETTS--(Marketwire - August 12, 2008) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced that Bob Doman, President & Chief Executive Officer will present at the Fourth Annual Noble Financial Equity Conference at 9:30 a.m. (Pacific) 12:30 Eastern on Tuesday, August 19, 2008 at the Loews Lake Las Vegas Resort, Nevada.
